President and CEO

Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares

Avidity raises $690m to advance RNA pipeline and Duchenne therapy

Avidity Biosciences initiated with bullish view at Roth Capital, here's why

Avidity Biosciences, Inc. Announces Closing of Upsized Public Offering of Common Stock, Including Full Exercise of Underwriters' Option to Purchase Additional Shares

Executive Director, Government Affairs & Policy

Avidity Biosciences, Inc. is focused on revolutionizing RNA therapeutics to improve patient lives. The Executive Director, Government Affairs & Policy will develop and execute government relations and policy strategies to support innovative therapies for rare diseases, serving as a liaison with policymakers and trade associations.

Chief Human Resources Officer

Vice President, Medical Affairs North America

Executive Director, Global Medical Affairs

Vice President, IP Law

Chief Business Officer

Sign up with Google

Sign in with Google